These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
518 related articles for article (PubMed ID: 19256578)
1. Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk. Schneider JP Geriatrics; 2009 Jan; 64(1):18-23. PubMed ID: 19256578 [TBL] [Abstract][Full Text] [Related]
2. Unusual subtrochanteric femoral insufficiency fractures associated with the prolonged use of alendronate and risedronate: a report of two cases. Angthong C; Angthong W J Med Assoc Thai; 2011 Dec; 94 Suppl 7():S214-20. PubMed ID: 22619933 [TBL] [Abstract][Full Text] [Related]
3. [New development in bisphosphonate treatment. When and how long should patients take bisphosphonates for osteoporosis?]. Yamaguchi T; Sugimoto T Clin Calcium; 2009 Jan; 19(1):38-43. PubMed ID: 19122263 [TBL] [Abstract][Full Text] [Related]
4. [Alendronate for treatment of osteoporoses]. Harada A Nihon Rinsho; 2009 May; 67(5):943-7. PubMed ID: 19432114 [TBL] [Abstract][Full Text] [Related]
5. Successful teriparatide treatment of atypical fracture after long-term use of alendronate without surgical procedure in a postmenopausal woman: a case report. Huang HT; Kang L; Huang PJ; Fu YC; Lin SY; Hsieh CH; Chen JC; Cheng YM; Chen CH Menopause; 2012 Dec; 19(12):1360-3. PubMed ID: 22968250 [TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. Black DM; Kelly MP; Genant HK; Palermo L; Eastell R; Bucci-Rechtweg C; Cauley J; Leung PC; Boonen S; Santora A; de Papp A; Bauer DC; ; N Engl J Med; 2010 May; 362(19):1761-71. PubMed ID: 20335571 [TBL] [Abstract][Full Text] [Related]
8. Bisphosphonates and atypical femoral fractures: a time for reflection. Compston JE Maturitas; 2010 Jan; 65(1):3-4. PubMed ID: 19932574 [No Abstract] [Full Text] [Related]
11. Atypical fractures on long term bisphosphonates therapy. Hussein W; Cunningham C; Logan H; Fallon C; Murphy S Ir Med J; 2011; 104(10):308, 310. PubMed ID: 22256444 [TBL] [Abstract][Full Text] [Related]
12. Femoral shaft fractures in the elderly--role of prior bisphosphonate therapy. Ng YH; Gino PD; Lingaraj K; Das De S Injury; 2011 Jul; 42(7):702-6. PubMed ID: 21316051 [TBL] [Abstract][Full Text] [Related]
13. Bilateral atypical femoral diaphyseal fractures in a patient treated with alendronate sodium. Lee JK Int J Rheum Dis; 2009 Jul; 12(2):149-54. PubMed ID: 20374333 [TBL] [Abstract][Full Text] [Related]
14. Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy. Capeci CM; Tejwani NC J Bone Joint Surg Am; 2009 Nov; 91(11):2556-61. PubMed ID: 19884427 [TBL] [Abstract][Full Text] [Related]
15. The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates. Rietbrock S; Olson M; van Staa TP QJM; 2009 Jan; 102(1):35-42. PubMed ID: 18842684 [TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate-associated atypical sub-trochanteric femur fractures: paired bone biopsy quantitative histomorphometry before and after teriparatide administration. Miller PD; McCarthy EF Semin Arthritis Rheum; 2015 Apr; 44(5):477-482. PubMed ID: 25312241 [TBL] [Abstract][Full Text] [Related]
18. [Is SSBT associated with atypical femoral fracture? SSBT isn't associated with atypical femoral fracture]. Soen S Clin Calcium; 2012 Jun; 22(6):919-22. PubMed ID: 22653034 [TBL] [Abstract][Full Text] [Related]
19. A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture. Cross MB; Nam D; van der Meulen MC; Bostrom MP J Bone Joint Surg Br; 2012 Jul; 94(7):994-7. PubMed ID: 22733959 [TBL] [Abstract][Full Text] [Related]